🇺🇸 FDA
Patent

US 9334306

Leukemia stem cell targeting ligands and methods of use

granted A61KA61K47/62A61K47/6907

Quick answer

US patent 9334306 (Leukemia stem cell targeting ligands and methods of use) held by The Regents of the University of California expires Mon May 05 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue May 10 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 05 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
23
CPC classes
A61K, A61K47/62, A61K47/6907, A61K51/08, A61P